Study of the Effect of Fostamatinib Twice Daily on Blood Pressure in Patients With Rheumatoid Arthritis
Clinical trial NCT01563978 · COMPLETED
Trial details
- NCT number
- NCT01563978
- Sponsor
- AstraZeneca
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-04-01
- Primary completion
- 2013-01-01
- Enrollment
- 266
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.